Abstract
To compare the rate of sphincter-saving interventions between transanal and laparoscopic Total Mesorectal Excision in this particular group of patients. A multicentre observational study was conducted using a prospective database, including patients diagnosed with rectal cancer below the peritoneal reflection and BMI ≥ 30 kg/m2, who underwent minimally invasive elective surgery over a 5-year period. Exclusion criteria were (1) sphincter and/or puborectalis invasion; (2) multi-visceral resections; (3) palliative surgeries. The study population was divided into two groups according to the intervention: transanal or laparoscopic total mesorectal excision. The primary outcome was the rate of sphincter-saving surgery. Secondary outcomes included conversion, postoperative complications, quality of the specimen, and survival. A total of 93 patients were included; 40 (43%) transanal total mesorectal excision were compared to 53 (57%) laparoscopic. In addition, 35 cases of transanal approach were case-matched with an equal number of laparoscopic approaches, based on gender, tumor’s height, and neoadjuvant therapy. In both groups, 43% of the patients had low rectal cancer; however, the rate of sphincter-saving surgery was significantly higher in the transanal group (97% vs. 71%, p = 0.003). There were no conversions to open surgery in the transanal group, compared to 2 cases in the laparoscopic group (6%) (p = 0.246). The percentage of major complications was similar, including the rate of anastomotic leakage (10% transanal vs. 19% laparoscopic, p = 0.835). In our experience, higher percentages of sphincter-saving procedures and lower conversion rates are potential benefits of using the transanal approach in a complex surgical setting population of obese patients with mid-low rectal tumors when compared to laparoscopic.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author, [PT], upon reasonable request.
Change history
22 November 2023
A Correction to this paper has been published: https://doi.org/10.1007/s13304-023-01705-2
References
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg 69:613–616. https://doi.org/10.1002/bjs.1800691019
Bonjer HJ, Deijen CL, Haglind E, COLOR II Study Group (2015) A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 373:194. https://doi.org/10.1056/NEJMc1505367
Stevenson ARL, Solomon MJ, Lumley JW et al (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314:1356–1363. https://doi.org/10.1001/jama.2015.12009
Fleshman J, Branda M, Sargent DJ et al (2015) Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314:1346–1355. https://doi.org/10.1001/jama.2015.10529
Aytac E, Lavery IC, Kalady MF, Kiran RP (2013) Impact of obesity on operation performed, complications, and long-term outcomes in terms of restoration of intestinal continuity for patients with mid and low rectal cancer. Dis Colon Rectum 56:689–697. https://doi.org/10.1097/DCR.0b013e3182880ffa
Rutgers ML, Detering R, Roodbeen SX et al (2021) Influence of minimally invasive resection technique on sphincter preservation and short-term outcome in low rectal cancer in the Netherlands. Dis Colon Rectum 64:1488–1500. https://doi.org/10.1097/dcr.0000000000001906
Penna M, Cunningham C, Hompes R (2017) Transanal total mesorectal excision: why, when, and how. Clin Colon Rectal Surg 30:339–345. https://doi.org/10.1055/s-0037-1606111
Carmichael H, Sylla P (2020) Evolution of transanal total mesorectal excision. Clin Colon Rectal Surg 33:113–127. https://doi.org/10.1055/s-0039-3402773
Rullier E, Denost Q, Vendrely V et al (2013) Low rectal cancer: classification and standardization of surgery. Dis Colon Rectum 56:560–567. https://doi.org/10.1097/DCR.0b013e31827c4a8c
Simo V, Tejedor P, Jimenez LM et al (2021) Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study. Surg Endosc 35:1808–1819. https://doi.org/10.1007/s00464-020-07579-4
Tejedor P, Jimenez LM, Simó V et al (2022) How to perform an anastomosis following a low anterior resection by transanal total mesorectal excision surgery: from top to bottom techniques. Colorectal Dis. https://doi.org/10.1111/codi.16058
Moran BJ, Holm T, Brannagan G et al (2014) The English national low rectal cancer development programme: key messages and future perspectives. Colorectal Dis 16:173–178. https://doi.org/10.1111/codi.12501
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Rahbari NN, Weitz J, Hohenberger W et al (2010) Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 147:339–351. https://doi.org/10.1016/j.surg.2009.10.012
Weiser MR (2018) AJCC 8th edition: colorectal cancer. Ann Surg Oncol 25:1454–1455. https://doi.org/10.1245/s10434-018-6462-1
Hol JC, Burghgraef TA, Rutgers MLW et al (2021) Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer: a retrospective propensity score-matched cohort study of short-term outcomes. Br J Surg 108:1380–1387. https://doi.org/10.1093/bjs/znab233
Sparreboom CL, Komen N, Rizopoulos D et al (2019) Transanal total mesorectal excision: how are we doing so far? Colorectal Dis 21:767–774. https://doi.org/10.1111/codi.14601
Gouvas N, Georgiou PA, Agalianos C et al (2018) Does conversion to open laparoscopically attempted rectal cancer cases affect short- and long-term outcomes? A systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 28:117–126. https://doi.org/10.1089/lap.2017.0112
Jayne D, Pigazzi A, Marshall H et al (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: The ROLARR Randomized Clinical Trial. JAMA 318:1569–1580. https://doi.org/10.1001/jama.2017.7219
Penna M, Hompes R, Arnold S et al (2019) Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: results from the International TaTME Registry. Ann Surg 269:700–711. https://doi.org/10.1097/SLA.0000000000002653
Rutgers MLW, Bemelman WA, Khan JS, Hompes R (2021) The role of transanal total mesorectal excision. Surg Oncol. https://doi.org/10.1016/j.suronc.2021.101695
Gardner IH, Kelley KA, Abdelmoaty WF et al (2022) Transanal total mesorectal excision outcomes for advanced rectal cancer in a complex surgical population. Surg Endosc 36:167–175. https://doi.org/10.1007/s00464-020-08251-7
Aubert M, Mege D, Panis Y (2020) Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach—a meta-analysis. Surg Endosc 34:3908–3919. https://doi.org/10.1007/s00464-019-07160-8
Lo Bianco S, Lanzafame K, Piazza CD et al (2022) Total mesorectal excision laparoscopic versus transanal approach for rectal cancer: a systematic review and meta-analysis. Ann Med Surg (Lond) 74:103260. https://doi.org/10.1016/j.amsu.2022.103260
Zeng Z, Luo S, Chen J et al (2020) Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial. Surg Endosc 34:3956–3962. https://doi.org/10.1007/s00464-019-07167-1
Lei PR, Ruan Y, Yang X et al (2018) Trans-anal or trans-abdominal total mesorectal excision? a systematic review and meta-analysis of recent comparative studies on perioperative outcomes and pathological result. Int J Surg 60:113–119
Perdawood SK, Kroeigaard J, Eriksen M, Mortensen P (2021) Transanal total mesorectal excision: the Slagelse experience 2013–2019. Surg Endosc 35:826–836. https://doi.org/10.1007/s00464-020-07454-2
Roodbeen SX, Spinelli A, Bemelman WA et al (2021) Local recurrence after transanal total mesorectal excision for rectal cancer: a multicenter cohort study. Ann Surg 274:359–366. https://doi.org/10.1097/SLA.0000000000003757
Larsen SG, Pfeffer F, Kørner H, Norwegian Colorectal Cancer Group (2019) Norwegian moratorium on transanal total mesorectal excision. Br J Surg 106:1120–1121. https://doi.org/10.1002/bjs.11287
Francis N, Penna M, Mackenzie H et al (2017) Consensus on structured training curriculum for transanal total mesorectal excision (TaTME). Surg Endosc 31:2711–2719. https://doi.org/10.1007/s00464-017-5562-5
Acknowledgements
The authors would like to thank Dr. Sara Rosenstone Calvo for editing this manuscript.
Funding
There is no funding.
Author information
Authors and Affiliations
Contributions
PT and CP contributed equally to analyzing the data and writing the manuscript. The rest of the authors critically revised the paper for important intellectual content. All authors have contributed to the work and agreed on the final version. This manuscript is not being considered by any other journal.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest.
Informed consent
Informed consent was obtained from all participants.
Research involving human and animal participants
All procedures performed in studies involving humans were in accordance with the ethical standards of the institutional research committee and the 1964 Helsinki Declaration and its later amendments.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original article has been updated: Due to Methods section update.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tejedor, P., Arredondo, J., Simó, V. et al. The role of transanal compared to laparoscopic total mesorectal excision (taTME vs. lapTME) for the treatment of mid-low rectal cancer in obese patients: outcomes of a multicenter propensity-matched analysis. Updates Surg 75, 2191–2200 (2023). https://doi.org/10.1007/s13304-023-01676-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-023-01676-4